VELPHORO(R) (sucroferric oxyhydroxide) chewable tablets - POTENCY MAKES ALL THE DIFFERENCE

Prescribing Information Important Safety Information Registration

For US Healthcare Professionals For Patients For Renal Dietitians

  • POTENCY
  • EFFICACY
  • FLEXIBILITY
  • TOLERABILITY
  • ACCESS
  • RESOURCES
  • FAQs

For US Healthcare Professionals
For Patients
For Renal Dietitians

  • Privacy Notice
  • Terms of Use
  • Notice of Privacy Practices
  • Contact Us
  • Site Map

SITEMAP

  • Home
  • Potency
  • Efficacy
  • Flexibility
  • Tolerability
  • Access
  • Resources
  • FAQs
  • Register

 

INDICATION

Velphoro® (sucroferric oxyhydroxide) is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.

IMPORTANT SAFETY INFORMATION

  • Velphoro chewable tablets must be administered with meals. Velphoro should be chewed or crushed. Do not swallow whole.
  • Patients with peritonitis during peritoneal dialysis, significant gastric or hepatic disorders, following major gastrointestinal (GI) surgery, or with a history of hemochromatosis or other diseases with iron accumulation have not been included in clinical studies with Velphoro. Monitor effect and iron homeostasis in such patients.
  • In a parallel design, fixed-dose study of 6 weeks duration, the most common adverse drug reactions to Velphoro chewable tablets in hemodialysis patients included discolored feces (12%) and diarrhea (6%).
  • Velphoro can be administered concomitantly with oral calcitriol, ciprofloxacin, digoxin, enalapril, furosemide, HMG-CoA reductase inhibitors, hydrochlorothiazide, losartan, metoprolol, nifedipine, omeprazole, quinidine and warfarin. For oral medications where a reduction of bioavailability would be clinically significant consider separating of the timing of administration. Consider monitoring clinical responses or blood levels of the concomitant medications.

For additional important safety information, please see the full Prescribing Information.

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Medical Care North America at 1-800-323-5188 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

This information is intended for use by US healthcare professionals only.

Distributed by:
Fresenius Medical Care North America
Waltham, MA 02451

PRIVACY NOTICE TERMS OF USE NOTICE OF PRIVACY PRACTICES PRESCRIBING INFORMATION CONTACT US SITE MAP

© 2019-2020 Fresenius Medical Care North America. All Rights Reserved. Fresenius Medical Care and the triangle logo are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. Velphoro is a registered trademark of Vifor Fresenius Medical Care Renal Pharma Ltd. All other trademarks are the property of their respective owners. Customer Service: 1-800-323-5188.

Fresenius Medical Care

You are now leaving velphorohcp.com

Continue